Literature DB >> 32904795

Reversible cerebral vasoconstriction syndrome: the importance of follow-up imaging within 2 weeks.

Kiyomitsu Fukaguchi1, Tadahiro Goto2, Hiroyuki Fukui1, Ichiro Sekine1, Hiroshi Yamagami1.   

Abstract

AIM: In patients with thunderclap headaches, reversible cerebral vasoconstriction syndrome (RCVS) should be considered as a differential diagnosis. However, RCVS diagnosis in the emergency department (ED) remains challenging. This report describes the clinical features and factors related to RCVS diagnosis and suggests diagnostic strategies for its management.
METHODS: We retrospectively reviewed the medical records of eight patients diagnosed with RCVS from January 2010 to March 2019 (aged 18-69 years, 5 women).
RESULTS: The median duration from the ED visit to RCVS diagnosis was 6 days (range, 1-11 days). Of the eight patients, seven were middle-aged, six had apparent triggers, six had subarachnoid hemorrhage (SAH), five had high systolic blood pressure, and none had any specific abnormality observed upon physical examination. At the initial visit, RCVS was diagnosed in only one patient who had a history of RCVS. Of the other patients, SAH was diagnosed in two, and primary headache was diagnosed in four patients with negative computed tomography (CT) findings. Based on follow-up angiography (e.g., magnetic resonance angiography), seven of eight patients with convexal SAH were diagnosed with RCVS (as the cause of SAH).
CONCLUSION: Reversible cerebral vasoconstriction syndrome with negative CT findings at the ED visit was likely to be misdiagnosed as a primary headache. In patients with thunderclap headache and negative CT findings, physicians should consider RCVS as a differential diagnosis, inform patients of the risk of RCVS, and undertake follow-up imaging within 2 weeks.
© 2020 The Authors. Acute Medicine & Surgery published by John Wiley & Sons Australia, Ltd on behalf of Japanese Association for Acute Medicine.

Entities:  

Keywords:  Primary headache; reversible cerebral vasoconstriction syndrome; thunderclap headache

Year:  2020        PMID: 32904795      PMCID: PMC7459196          DOI: 10.1002/ams2.559

Source DB:  PubMed          Journal:  Acute Med Surg        ISSN: 2052-8817


Introduction

Thunderclap headache, which refers to a very severe headache of abrupt onset that reaches its maximum intensity within 1 min or less of onset, is implicated in several serious conditions, including aneurysmal subarachnoid hemorrhage (SAH). Recent studies have underscored the importance and prevalence of reversible cerebral vasoconstriction syndrome (RCVS) among patients with thunderclap headache. , Reversible cerebral vasoconstriction syndrome is a relatively new disease concept, defined by Calabrese et al. in 2007. , Symptoms of RCVS include thunderclap headache, occasional minor bleeding (as in SAH), and focal neurological symptoms caused by reversible segmental spasms in the cerebral blood vessels. Although RCVS was thought to be a benign condition, recent studies have reported that RCVS can cause premature stroke and recurrent headaches. Despite its clinical importance, there are few emergency department (ED)‐based studies and no optimal strategies to manage patients with suspected RCVS. We describe the clinical features and course of RCVS among eight patients who presented at the ED. We also describe the factors related to RCVS diagnosis and report a strategy to manage patients suspected of having RCVS.

Methods

We retrospectively identified patients who were diagnosed at Shonan Kamakura General Hospital (Kamakura, Japan) with RCVS between January 2010 and March 2019 using the relevant code from the International Classification of Disease, 10th Revision. We reviewed their medical records for patient characteristics, medical history (e.g., triggers of headache), clinical features, diagnostic tests carried out at first ED visit, imaging findings at the time of diagnosis, number of days from onset of headache to diagnosis, and number of days from confirmation of vasospasm. This study was approved by the hospital’s Institutional Review Board, and the need for written informed consent was waived.

Results

Patient characteristics and clinical features of the eight RCVS cases are summarized in Table 1. The median age was 55 years (range, 18–69 years), and five patients were women. Seven patients visited the ED for thunderclap headache, and one patient visited for headache with syncope. Based on medical histories, varying causes, including sexual intercourse, beating of drums at a festival, physical or emotional stress, exertion, and urinary tract infection, were thought to be triggers of RCVS. Three patients had comorbidity with migraine or chronic headaches, and one patient had a history of RCVS.
Table 1

Clinical features of eight patients with reversible cerebral vasoconstriction syndrome (RCVS) in the emergency department (ED)

Case numberAge (years), sexVisit seasonChief complaintsPotential triggerComorbiditiesPulse rate, b.p.m.Blood pressure, mmHgPhysical examinations including neck stiffnessInitial imaging findingsInitial ED diagnosisDisposition
160, FAutumnThunderclap headacheSexual intercourseChronic headache97159/104No abnormalityNo specific CT findingsPrimary headache (RCVS was not suspected)Home
266, FSummerThunderclap headache, vomitingBeating drumsNone75160/95No abnormalityFinding of cSAH by CTcSAHHospitalization
318, MAutumnThunderclap headache, vomitingPhysical and emotional stress (dietary restriction and school exam)RCVS (2 years ago), migraine9995/57No abnormalityNo specific CT findings. Peripheral cerebral vasospasm of the left MCA by MRARCVSHospitalization
451, FSpringThunderclap headacheUnknownHypertension, cerebral infarction92132/84No abnormalityNo specific CT or MRI findingsPrimary headache (RCVS was not suspected)Home
558, FSummerThunderclap headacheEmotional stress (death of her daughter)Migraine, insomnia56148/76No abnormalityNo specific CT findingsPrimary headache (RCVS was not suspected)Home
651, FWinterThunderclap headache, nauseaExertion (ran in a hurry)Menopausal disorder72159/97No abnormalityNo specific CT findingsPrimary headache (RCVS was not suspected)Home
765, MSummerHeadache, syncopeUnknownDiabetes85162/89No abnormalityFinding of cSAH by CTcSAHHospitalization
869, MAutumnThunderclap headache, feverUTIDiabetes, chronic kidney disease92112/81No abnormalityNo specific CT and MRI findingsUTI, primary headache (RCVS was not suspected)Hospitalization

cSAH, convexal subarachnoid hemorrhage; CT, computed tomography; F, female; M, male; MCA, middle cerebral artery; MRA, magnetic resonance angiography; MRI, magnetic resonance imaging; UTI, urinary tract infection.

Clinical features of eight patients with reversible cerebral vasoconstriction syndrome (RCVS) in the emergency department (ED) cSAH, convexal subarachnoid hemorrhage; CT, computed tomography; F, female; M, male; MCA, middle cerebral artery; MRA, magnetic resonance angiography; MRI, magnetic resonance imaging; UTI, urinary tract infection. The mean pulse rate, mean systolic blood pressure, and mean diastolic blood pressure were 84 b.p.m. (range, 56–99 b.p.m.), 141 mmHg (range, 95–162 mmHg), and 85 mmHg (range, 57–104 mmHg), respectively. Physical and neurological examinations did not reveal any specific findings (including neck stiffness). Head computed tomography (CT) was carried out at the ED visit in all cases, but abnormalities were only observed in two patients with SAH. Magnetic resonance imaging (MRI) was carried out on three patients, with no specific findings. Five out of eight patients were initially diagnosed with primary headache. In these patients, there was no history suggestive of RCVS, and four patients were discharged without further instructions. These four patients returned to the ED due to recurrent (or persistent) severe headache and were then diagnosed with SAH (as a comorbid condition of RCVS). Of the three other patients, SAH was diagnosed in two, and RCVS was diagnosed in one. The RCVS patient had a history of RCVS; this patient showed vasospasm on MRI. Among the seven patients who were not diagnosed with RCVS at the initial visit, follow‐up imaging was undertaken within 2 weeks (range, 2–11 days; Table 2). Imaging revealed SAH in all seven cases with a slight pericortical hematoma as a complication of RCVS. These seven patients were diagnosed with RCVS following further assessment of SAH using angiography. None of the patients had an aneurysm. Diagnosis of vasospasm was made using magnetic resonance angiography (MRA), CT angiography, and digital subtraction angiography in five, one, and two patients, respectively. The sites of vasospasm were the middle cerebral artery and diffuse and multiple vessels in three and five patients, respectively. Improvement in vasospasm was later confirmed in seven patients. One patient died of a cause other than intracranial disease.
Table 2

Clinical course of eight case of reversible cerebral vasoconstriction syndrome (RCVS)

Case numberTime from initial ED visit to RCVS diagnosis (days from onset of headache)Diagnostic deviceImaging findings and site of spasmRCVS related complicationsPrognosis
12 (7)MRASpasm of right MCA (M1)Frontal lobe cSAH (MRI)Confirmed improvement of spasm 3 months later by CTA
25 (10)DSASpasm of segmental diffuse cerebral arteryParietal lobe cSAH (CT)Confirmed improvement of spasm 3 months later by MRA
31 (1)MRASpasm of peripheral cerebral artery of left MCA (M2)NoneConfirmed improvement of spasm 1 month later by MRA
49 (9)MRASpasm of cerebral artery of right MCA (M2)Frontal lobe cSAH (MRI)Confirmed improvement of spasm 6 months later by MRA
57 (10)DSASpasm of both sides of PCA and right MCA

Occipital lobe

cSAH (MRI)

Confirmed improvement of spasm 3 months later by MRA
66 (6)MRASpasm of peripheral cerebral arteries of fornix and posterior circulationParietal lobe cSAH (MRI)Confirmed improvement of spasm 3 months later by MRA
711 (13)MRASpasm of both sides of MCALeft temporal lobe cSAH (CT)Confirmed improvement of spasm 6 months later by MRA
86 (6)CTASpasm of both sides of PCAOccipital lobe cSAH (CT)

Not checked

Death

Two of eight cases (case numbers 4 and 5) received cerebrospinal fluid examination at the repeated emergency department (ED) visits or hospitalization for convexal subarachnoid hemorrhage (cSAH), without any specific findings indicating primary angiitis of the central nervous system. No patients received cerebrospinal fluid examination at the initial ED visit.

CT, computed tomography, CTA, computed tomography angiography; DSA, digital subtraction angiography; M1, M1 segment (horizontal/sphenoidal part) of MCA; M2, M2 segment (insular part) of MCA; MCA, middle cerebral artery; MRA, magnetic resonance angiography; MRI, magnetic resonance imaging; PCA, posterior cerebral artery.

Clinical course of eight case of reversible cerebral vasoconstriction syndrome (RCVS) Occipital lobe cSAH (MRI) Not checked Death Two of eight cases (case numbers 4 and 5) received cerebrospinal fluid examination at the repeated emergency department (ED) visits or hospitalization for convexal subarachnoid hemorrhage (cSAH), without any specific findings indicating primary angiitis of the central nervous system. No patients received cerebrospinal fluid examination at the initial ED visit. CT, computed tomography, CTA, computed tomography angiography; DSA, digital subtraction angiography; M1, M1 segment (horizontal/sphenoidal part) of MCA; M2, M2 segment (insular part) of MCA; MCA, middle cerebral artery; MRA, magnetic resonance angiography; MRI, magnetic resonance imaging; PCA, posterior cerebral artery.

Discussion

We found two important points for managing patients with suspected RCVS. First, RCVS could be misdiagnosed as primary headache in patients with no complications (e.g., SAH). Second, in patients with thunderclap headache and negative CT findings, RCVS should be considered as a differential diagnosis and the patient should be followed up with imaging (e.g., MRI, MRA) within 2 weeks of the visit. Although RCVS diagnosis is obviously difficult at the ED, management of these patients should be an important basis for emergency care. Reversible cerebral vasoconstriction syndrome typically occurs in the middle‐aged population along with thunderclap headache involving nausea/vomiting. Like other cardio‐ or cerebrovascular diseases, the presence of triggers could be important. Potential RCVS triggers include use of vasoactive drugs (e.g., triptans and selective serotonin reuptake inhibitors), bathing, and sexual activity. , In our study, reported characteristics of the eight patients with RCVS are consistent with those described previously and are similar to those of aneurysmal SAH – middle‐aged patients (n = 7/8) that visited the ED for thunderclap headache with nausea/vomiting (n = 7/8), apparent triggers (n = 6/8), SAH (hypertension, diabetes, migraine) risk (n = 6/8), high systolic blood pressure (≥140 mmHg) at the ED visit (n = 5/8), and no specific abnormality during physical examination (n = 8/8). There were no specific CT findings in six of the eight patients with RCVS. These results highlight the difficulty in diagnosing RCVS based on present illness, vital signs, and physical findings, although apparent triggers could be somewhat beneficial. Therefore, in the case of thunderclap headache with negative CT findings, physicians should consider RCVS as a differential diagnosis, inform the patient of the potential risk of RCVS, and record the potential diagnosis in the patient’s medical chart for further review. Additionally, RCVS diagnosis is difficult because of the inconsistency in the duration between the onset of headache and the vasospasm imaging findings. Reversible cerebral vasoconstriction syndrome imaging features are often normal in the early stages of severe headache. Consistent with observations reported in previous studies, , , an average of 8 days was required to confirm vasospasm in this study. Previous studies revealed that vasospasm occurred over time from the peripheral side to the central side of the cerebral artery, , , , and the appropriate timing of the image evaluation is considered to be 1–2 weeks after the onset of headache. However, by this time, the headache tends to improve, and thereafter, the patients no longer felt they needed treatment. Although studies have reported that the prognosis of RCVS was generally good, recent studies have indicated the risk concurrent with SAH, as well as other complications in patients with RCVS, such as SAH (22–34%), cerebral hemorrhage (6–12%), and cerebral infarction (4–10%). , , , , These complications are likely to occur at an early stage. Due to no RCVS‐specific findings at the initial patient presentation, these complications could be the key to earlier diagnosis. Conversely, because cerebrovascular complications are reported in 20–30% of RCVS, approximately 70–80% of RCVS patients without complications are likely to be misdiagnosed. In our study, four patients had slight hematomas that were not detected by CT and required further imaging using MRI. Magnetic resonance imaging could be helpful in distinguishing between SAH and RCVS and other common, non‐life‐threatening conditions. Patients with undiagnosed RCVS are at risk of frequent ED visits and of receiving inappropriate therapy. Triggers have been reported in approximately 50% of patients with RCVS, and some of these triggers could help with patient diagnosis. An accurate RCVS diagnosis can improve patient outcomes. Therefore, accurate diagnosis of RCVS at an early stage is critical.

Conclusion

In eight cases of RCVS presenting at an initial ED visit, there were no specific findings based on presenting illness, vital signs, physical examination, or CT imaging. As prompt diagnosis of RCVS is difficult at the ED, for patients with thunderclap headache and negative CT findings, physicians should consider RCVS as a differential diagnosis, inform patients of the risk of RCVS, and undertake follow‐up imaging within 2 weeks. Early diagnosis of RCVS could result in improved patient outcomes and the reduction of unnecessary ED visits.

Disclosure

Approval of the Research Protocol: This study was approved by the hospital’s Institutional Review Board. Informed Consent: The requirement of written informed consent was waived. Registry and the Registration no. of the study/trial: N/A. Animal Studies: N/A. Conflict of Interest: None.
  15 in total

Review 1.  Narrative review: reversible cerebral vasoconstriction syndromes.

Authors:  Leonard H Calabrese; David W Dodick; Todd J Schwedt; Aneesh B Singhal
Journal:  Ann Intern Med       Date:  2007-01-02       Impact factor: 25.391

Review 2.  Managing Patients With Nontraumatic, Severe, Rapid-Onset Headache.

Authors:  Jonathan A Edlow
Journal:  Ann Emerg Med       Date:  2018-03       Impact factor: 5.721

Review 3.  Thunderclap headache.

Authors:  Anne Ducros; Marie-Germaine Bousser
Journal:  BMJ       Date:  2013-01-08

4.  Magnetic resonance angiography in reversible cerebral vasoconstriction syndromes.

Authors:  Shih-Pin Chen; Jong-Ling Fuh; Shuu-Jiun Wang; Feng-Chi Chang; Jiing-Feng Lirng; Ying-Chen Fang; Ben-Chang Shia; Jaw-Ching Wu
Journal:  Ann Neurol       Date:  2010-05       Impact factor: 10.422

5.  Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition.

Authors: 
Journal:  Cephalalgia       Date:  2018-01       Impact factor: 6.292

Review 6.  Reversible Cerebral Vasoconstriction Syndrome, Part 1: Epidemiology, Pathogenesis, and Clinical Course.

Authors:  T R Miller; R Shivashankar; M Mossa-Basha; D Gandhi
Journal:  AJNR Am J Neuroradiol       Date:  2015-01-15       Impact factor: 3.825

Review 7.  Systematic review of reversible cerebral vasoconstriction syndrome.

Authors:  Ahsan Sattar; Georgios Manousakis; Matthew B Jensen
Journal:  Expert Rev Cardiovasc Ther       Date:  2010-10

Review 8.  Reversible Cerebral Vasoconstriction Syndrome, Part 2: Diagnostic Work-Up, Imaging Evaluation, and Differential Diagnosis.

Authors:  T R Miller; R Shivashankar; M Mossa-Basha; D Gandhi
Journal:  AJNR Am J Neuroradiol       Date:  2015-01-22       Impact factor: 3.825

9.  The clinical and radiological spectrum of reversible cerebral vasoconstriction syndrome. A prospective series of 67 patients.

Authors:  Anne Ducros; Monique Boukobza; Raphaël Porcher; Mariana Sarov; Dominique Valade; Marie-Germaine Bousser
Journal:  Brain       Date:  2007-11-19       Impact factor: 13.501

10.  Centripetal Propagation of Vasoconstriction at the Time of Headache Resolution in Patients with Reversible Cerebral Vasoconstriction Syndrome.

Authors:  M Shimoda; S Oda; A Hirayama; M Imai; F Komatsu; K Hoshikawa; H Shigematsu; J Nishiyama; T Osada
Journal:  AJNR Am J Neuroradiol       Date:  2016-04-14       Impact factor: 3.825

View more
  1 in total

Review 1.  Reversible cerebral vasoconstriction syndrome: review of neuroimaging findings.

Authors:  Teresa Perillo; Chiara Paolella; Giulia Perrotta; Antonietta Serino; Ferdinando Caranci; Andrea Manto
Journal:  Radiol Med       Date:  2022-08-06       Impact factor: 6.313

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.